OJ-328 ACE-Inhibitor and angiotensin II receptor antagonists (ARB) have stronger effects on matrix metalloproteinase pathway of collagen degradation compared to Ca-antagonists(Cardiovascular Pharmacology, Basic/Clinical 2 (H) : OJ39)(Oral Presentation (Japanese))